Chemo patch for skin cancer shows early promise in small trial
NCT ID NCT03646188
First seen Apr 28, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This early-stage trial tested a new way to treat basal cell carcinoma (a common skin cancer) using tiny needles on a patch that deliver the chemotherapy drug doxorubicin directly into the tumor. The study involved 13 adults with small, untreated skin cancers. The goal was to find the safest dose and see if the patch could completely remove the cancer. The trial was stopped early, but results helped understand safety and dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Center for Clinical and Cosmetic Research
Aventura, Florida, 33180, United States
Conditions
Explore the condition pages connected to this study.